Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer

Comprehensive genomic profiling (CGP) testing by next‐generation sequencing has been introduced into clinical practice as part of precision cancer medicine to select effective targeted therapies. However, whether CGP testing at the time of first‐line chemotherapy could be clinically useful is not cl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Sci
Auteurs principaux: Kondo, Tomohiro, Matsubara, Junichi, Quy, Pham Nguyen, Fukuyama, Keita, Nomura, Motoo, Funakoshi, Taro, Doi, Keitaro, Sakamori, Yuichi, Yoshioka, Masahiro, Yokoyama, Akira, Tamaoki, Masashi, Kou, Tadayuki, Hirohashi, Kenshiro, Yamada, Atsushi, Yamamoto, Yoshihiro, Minamiguchi, Sachiko, Nishigaki, Masakazu, Yamada, Takahiro, Kanai, Masashi, Matsumoto, Shigemi, Muto, Manabu
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780032/
https://ncbi.nlm.nih.gov/pubmed/33007138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14674
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires